FDA
approval
· 2020-09-03
FDA Approved: TRAVOPROST — Supplemental Application (Apotex Corp.)
Summary
FDA approved a supplemental application from Apotex Corp. for Travoprost (ophthalmic) under an ANDA, granting additional regulatory clearance for this generic p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRAVOPROST (TRAVOPROST)